Jianqing Lin

Jianqing Lin

Auto-generated profile, based on publicly available information

Jianqing Lin

NTU Institute of Structural Biology, Nanyang Technological University, Singapore; School of Biological Sciences, Nanyang Technological University, Singapore

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 July 2021 in Nature Microbiology
Verified
Journal Article
Closed access
Benoit MalleretBenoit Malleret
Benoit Malleret
ASAbbas El Sahili
Abbas El Sahili
MTMatthew Zirui Tay
Matthew Zirui Tay
GCGuillaume Carissimo
Guillaume Carissimo
AOAlice Soh Meoy Ong
Alice Soh Meoy Ong
LRLaurent Renia
Laurent Renia

22 September 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
Zhiqiang KuZhiqiang Ku
Zhiqiang Ku
XXXuping Xie
Xuping Xie
JLJianqing Lin
Jianqing Lin
PGPeng Gao
Peng Gao
BWBin Wu
Bin Wu
ZAZhiqiang An
Zhiqiang An
One major limitation of neutralizing antibody-based COVID-19 therapy is the requirement of costly cocktails to reduce emergence of antibody resistance. Here we engineer two bispecific antibodies (bsAbs) using distinct designs and compared them with parental antibodies and their cocktail. Single molecules of both bsAbs block the two epitopes targeted by parental antibodies on the receptor-binding domain (RBD). However, bsAb with the IgG-(scFv)2 design (14-H-06) but not the CrossMAb design (14-crs-06) shows increased antigen-binding and virus-neutralizing activities against multiple SARS-CoV-2 variants as well as increased breadth of neutralizing activity compared to the cocktail. X-ray crystallography and cryo-EM reveal distinct binding models for individual cocktail antibodies, and computational simulations suggest higher inter-spike crosslinking potentials by 14-H-06 than 14-crs-06. In mouse models of infections by SARS-CoV-2 and multiple variants, 14-H-06 exhibits higher or equivalent therapeutic efficacy than the cocktail. Rationally engineered bsAbs represent a cost-effective alternative to antibody cocktails and a promising strategy to improve potency and breadth.

1 November 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
NTNikhil Tulsian
Nikhil Tulsian
RPRaghuvamsi Venkata Palur
Raghuvamsi Venkata Palur
XQXinlei Qian
Xinlei Qian
YGYue Gu
Yue Gu
BSBhuvaneshwari D/O Shunmuganathan
Bhuvaneshwari D/O Shunmuganathan
PMPaul A. MacAry
Paul A. MacAry
The changing landscape of SARS-CoV-2 Spike protein is linked to the emergence of variants, immune-escape and reduced efficacy of the existing repertoire of anti-viral antibodies. The functional activity of neutralizing antibodies is linked to their quaternary changes occurring as a result of antibody-Spike trimer interactions. Here, we reveal the conformational dynamics and allosteric perturbations linked to binding of novel human antibodies and the viral Spike protein. We identified epitope hotspots, and associated changes in Spike dynamics that distinguish weak, moderate and strong neutralizing antibodies. We show the impact of mutations in Wuhan-Hu-1, Delta, and Omicron variants on differences in the antibody-induced conformational changes in Spike and illustrate how these render certain antibodies ineffective. Antibodies with similar binding affinities may induce destabilizing or stabilizing allosteric effects on Spike, with implications for neutralization efficacy. Our results provide mechanistic insights into the functional modes and synergistic behavior of human antibodies against COVID-19 and may assist in designing effective antiviral strategies.

9 May 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
DRDavid Ruiz-Carrillo
David Ruiz-Carrillo
JLJianqing Lin
Jianqing Lin
ASAbbas El Sahili
Abbas El Sahili
MWMeng Wei
Meng Wei
SSSiu Kwan Sze
Siu Kwan Sze
JLJulien Lescar
Julien Lescar
Malaria causes every year over half-a-million deaths. The emergence of parasites resistant to available treatments makes the identification of new targets and their inhibitors an urgent task for the development of novel anti-malaria drugs. Protein kinase CK2 is an evolutionary-conserved eukaryotic serine/threonine protein kinase that inPlasmodium falciparum(PfCK2) has been characterized as a promising target for chemotherapeutic intervention against malaria. Here we report a crystallographic structure of the catalytic domain ofPfCK2α (D179S inactive single mutant) in complex with ATP at a resolution of 3.0 Å. Compared to the human enzyme, the structure reveals a subtly altered ATP binding pocket comprising five substitutions in the vicinity of the adenine base, that together with potential allosteric sites, could be exploited to design novel inhibitors specifically targeting thePlasmodiumenzyme. We provide evidence for the dual autophosphorylation of residues Thr63and Tyr30ofPfCK2. We also show that CX4945, a human CK2 inhibitor in clinical trials against solid tumor cancers, is effective againstPfCK2 with an IC50of 13.2 nM.

6 November 2020 in PLOS ONE
Verified
Journal Article
Open access
PDF file
WPWee-Han Poh
Wee-Han Poh
JLJianqing Lin
Jianqing Lin
BCBrendan Colley
Brendan Colley
NMNicolai Müller
Nicolai Müller
BGBoon Chong Goh
Boon Chong Goh
JKJanosch Klebensberger
Janosch Klebensberger
The critical role of bacterial biofilms in chronic human infections calls for novel anti-biofilm strategies targeting the regulation of biofilm development. However, the regulation of biofilm development is very complex and can include multiple, highly interconnected signal transduction/response pathways, which are incompletely understood. We demonstrated previously that in the opportunistic, human pathogen P. aeruginosa, the PP2C-like protein phosphatase SiaA and the di-guanylate cyclase SiaD control the formation of macroscopic cellular aggregates, a type of suspended biofilms, in response to surfactant stress. In this study, we demonstrate that the SiaABC proteins represent a signal response pathway that functions through a partner switch mechanism to control biofilm formation. We also demonstrate that SiaABCD functionality is dependent on carbon substrate availability for a variety of substrates, and that upon carbon starvation, SiaB mutants show impaired dispersal, in particular with the primary fermentation product ethanol. This suggests that carbon availability is at least one of the key environmental cues integrated by the SiaABCD system. Further, our biochemical, physiological and crystallographic data reveals that the phosphatase SiaA and its kinase counterpart SiaB balance the phosphorylation status of their target protein SiaC at threonine 68 (T68). Crystallographic analysis of the SiaA-PP2C domain shows that SiaA is present as a dimer. Dynamic modelling of SiaA with SiaC suggested that SiaA interacts strongly with phosphorylated SiaC and dissociates rapidly upon dephosphorylation of SiaC. Further, we show that the known phosphatase inhibitor fumonisin inhibits SiaA mediated phosphatase activity in vitro. In conclusion, the present work improves our understanding of how P. aeuruginosa integrates specific environmental conditions, such as carbon availability and surfactant stress, to regulate cellular aggregation and biofilm formation. With the biochemical and structural characterization of SiaA, initial data on the catalytic inhibition of SiaA, and the interaction between SiaA and SiaC, our study identifies promising targets for the development of biofilm-interference drugs to combat infections of this aggressive opportunistic pathogen.

1 June 2019 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
LDLiang Dai
Liang Dai
JLJianqing Lin
Jianqing Lin
ASAminahtusaidah Binte Said
Aminahtusaidah Binte Said
YYYin Hoe Yau
Yin Hoe Yau
SSSusana Geifman Shochat
Susana Geifman Shochat
PCPeter Cf. Cheung
Peter Cf. Cheung